Teva Pharmaceutical Statistics
Total Valuation
TEVA has a market cap or net worth of $14.42 billion. The enterprise value is $31.34 billion.
| Market Cap | 14.42B |
| Enterprise Value | 31.34B |
Important Dates
The next confirmed earnings date is Wednesday, May 8, 2024, before market open.
| Earnings Date | May 8, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
TEVA has 1.12 billion shares outstanding.
| Shares Outstanding | 1.12B |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 52.60% |
| Float | 1.11B |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 5.59 |
| PS Ratio | 0.91 |
| Forward PS | 0.89 |
| PB Ratio | 1.92 |
| P/FCF Ratio | 17.12 |
| PEG Ratio | 1.84 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 19.07, with an EV/FCF ratio of 37.22.
| EV / Earnings | n/a |
| EV / Sales | 1.98 |
| EV / EBITDA | 19.07 |
| EV / EBIT | 63.83 |
| EV / FCF | 37.22 |
Financial Position
The company has a current ratio of 1.02, with a Debt / Equity ratio of 2.68.
| Current Ratio | 1.02 |
| Quick Ratio | 0.54 |
| Debt / Equity | 2.68 |
| Debt / EBITDA | 12.26 |
| Debt / FCF | 23.93 |
| Interest Coverage | 0.46 |
Financial Efficiency
Return on equity (ROE) is -7.60%.
| Return on Equity (ROE) | -7.60% |
| Return on Assets (ROA) | -1.30% |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | $418,642 |
| Profits Per Employee | -$14,768 |
| Employee Count | 37,851 |
| Asset Turnover | 0.37 |
| Inventory Turnover | 2.09 |
Taxes
| Income Tax | -7.00M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +51.47% in the last 52 weeks. The beta is 1.06, so TEVA's price volatility has been similar to the market average.
| Beta (1Y) | 1.06 |
| 52-Week Price Change | +51.47% |
| 50-Day Moving Average | 13.44 |
| 200-Day Moving Average | 10.67 |
| Relative Strength Index (RSI) | 36.61 |
| Average Volume (30 Days) | 10,492,993 |
Short Selling Information
| Short Interest | 11.56M |
| Short Previous Month | 14.72M |
| Short % of Shares Out | 1.79% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 1.34 |
Income Statement
In the last 12 months, TEVA had revenue of $15.85 billion and -$559.00 million in losses. Loss per share was -$0.50.
| Revenue | 15.85B |
| Gross Profit | 7.65B |
| Operating Income | 433.00M |
| Pretax Income | -566.00M |
| Net Income | -559.00M |
| EBITDA | 1.64B |
| EBIT | 491.00M |
| Loss Per Share | -$0.50 |
Balance Sheet
The company has $3.23 billion in cash and $20.15 billion in debt, giving a net cash position of -$16.93 billion or -$15.10 per share.
| Cash & Cash Equivalents | 3.23B |
| Total Debt | 20.15B |
| Net Cash | -16.93B |
| Net Cash Per Share | -$15.10 |
| Equity / Book Value | 7.51B |
| Book Value Per Share | 6.70 |
| Working Capital | 238.00M |
Cash Flow
In the last 12 months, operating cash flow was $1.37 billion and capital expenditures -$526.00 million, giving a free cash flow of $842.00 million.
| Operating Cash Flow | 1.37B |
| Capital Expenditures | -526.00M |
| Free Cash Flow | 842.00M |
| FCF Per Share | $0.75 |
Margins
Gross margin is 48.25%, with operating and profit margins of 2.73% and -3.53%.
| Gross Margin | 48.25% |
| Operating Margin | 2.73% |
| Pretax Margin | -3.57% |
| Profit Margin | -3.53% |
| EBITDA Margin | 10.37% |
| EBIT Margin | 3.10% |
| FCF Margin | 5.31% |
Dividends & Yields
TEVA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.81% |
| Shareholder Yield | -0.81% |
| Earnings Yield | -3.88% |
| FCF Yield | 5.84% |
Analyst Forecast
The average price target for TEVA is $13.78, which is 7.15% higher than the current price. The consensus rating is "Buy".
| Price Target | $13.78 |
| Price Target Difference | 7.15% |
| Analyst Consensus | Buy |
| Analyst Count | 10 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on July 1, 2004. It was a forward split with a ratio of 2:1.
| Last Split Date | Jul 1, 2004 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
TEVA has an Altman Z-Score of 0.22 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.22 |
| Piotroski F-Score | 5 |